President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentmyJoslin | Patient PortalAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Agents of Change: Systems and Strategies to Address Family, Social, and Developmental Needs in the Type 1 Pediatric Population

Activity Description

This activity is supported in an educational grant from Lilly USA, LLC.

CME Release Date: 7/30/2012
CME Expiration Date: 7/30/2013

Statement of Need

The well-documented increase in the incidence of type 1 diabetes in children and adolescents is a significant concern from a healthcare delivery perspective. More and more of these young people are being cared for by pediatricians, and diabetes educators are increasingly being called upon to provide educational support specifically tailored to this population despite having little training in pediatric care, particularly in the areas of growth and development and issues such as family dynamics, and how these intersect and affect diabetes-related issues. Diabetes education that addresses family and developmental issues is at least as important—sometimes even more important—than the basics of diabetes care, such as insulin adjustments and plans.

The goal of this activity is to improve both systems of care and clinical skills in caring for pediatric diabetes patients. To that end, it will cover not only the medical care, growth, and developmental needs of this challenging population, but also the diabetes educator’s role as an agent of change in developing office systems and educational strategies for optimizing the care of children and adolescents with type 1 diabetes.

Target Audience

Target audience include primary care physicians, physician assistants, nurses, nurse practitioners, diabetes nurse educators, dieticians, pharmacists, and other allied healthcare professionals treating young patients with type 1 diabetes.

Learning Objectives

Upon completion of this program participants will be able to:

  • Describe the differences in educational and psychological support typically needed by a child with diabetes compared to an adult with diabetes.
  • Assess ones own practice for its ability to provide the state-of-the-art care and support needed by young people with type 1 diabetes, and how well that care and support extends to local providers caring for these people as well.
  • Apply strategies to more effectively insure that children and adolescents with type 1 diabetes are offered needed support for concurrent growth and development issues in the context of their own practices.
  • Describe the potential role of a diabetes educator as an agent of change in the provision of diabetes care for young people with type 1 diabetes in this era of evolving health systems.

Faculty and Disclosures

Korey Hood, PhD
Associate Professor of Pediatrics
Staff Psychologist
Cincinnati Children's Hospital
Cincinnati, OH

Disclosure
Korey Hood, PhD, is on the speakers bureau for Animas Corporation

Lori Laffel, MD, MPH
Associate Professor of Pediatrics
Harvard Medical School
Chief, Pediatric, Adolescent and Young Adult Section
Investigator, Genetics and Epidemiology Section
Joslin Diabetes Center
Boston, MA

Disclosure
Lori Laffel, MD, MPH, is on the speakers bureau for Johnson & Johnson; is a consultant for AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, and Novo Nordisk Inc.; receives grant/research support from Bayer; and is a consultant and on the speakers bureau for Menarini Group and sanofi-aventis U.S. Inc.

Jean Betschart Roemer, MN, MSN, CRNP, CPNP, CDE
Pediatric Nurse Practitioner
Department of Endocrinology Diabetes and Metabolism
Children’s Hospital of Pittsburgh – UPMC
Pittsburgh, PA

Disclosure
Jean Betschart Roemer MSN, MN, CPNP, CDE, is a consultant for Medtronic MiniMed and receives grant/research support from Novo Nordisk Inc.

Planning Committee:

Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director, Professional Education
Joslin Diabetes Center
Boston, MA

Disclosure
Richard S. Beaser is a consultant for AstraZeneca/Bristol-Myers Squibb Company and CeQur Ltd

Julie A. Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA

Disclosure
Julie A. Brown is a consultant for AstraZeneca/Bristol-Myers Squibb Company.

Melinda D. Maryniuk, MEd, RD, CDE
Director, Clinical Education Programs
Strategic Initiatives
Joslin Diabetes Center
Boston, MA

Disclosure
Melinda Maryniuk is a consultant for Eli Lilly and Company.

Carolé Mensing, RN, MA, CDE, FAADE
Manager, Education and Clinical Services
Joslin Diabetes Center
Boston, MA

Disclosure
Carolé Mensing is a consultant for Novo Nordisk Inc.

Cindy Pasquarello, BSN, RN, CDE
Nurse Manager
Pediatric, Adolescent, and Young Adult Unit
Joslin Clinic
Boston, MA

Disclosure
Cindy Pasquarello has no relevant financial relationships.

CME Advisory Committee

Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is a consultant for AstraZeneca/Bristol-Myers Squibb Company and CeQur Ltd.

Julie A. Brown, Director, Professional Education, Joslin Diabetes Center, is a consultant for AstraZeneca/Bristol-Myers Squibb Company.

Dr. Enrique Caballero, Director, Medical Affairs, Professional Education, Director, Latino Diabetes Initiative, Joslin Diabetes Center, is a consultant and on the speakers bureau and scientific advisory board for Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., and Eli Lilly and Company.

Dr. Jerry Cavallerano, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.

Dr. A. Patrick Egan, Family Practice, Internal Medicine Specialist, Dorchester House Multi-Service Center, has no relevant financial relationships.

Anne E. Goebel-Fabbri, Psychologist, Behavioral and Mental Health Unit, Joslin Diabetes Center, has no relevant financial relationships.

Dr. Osama Hamdy, Medical Director, Obesity Clinical Program, Joslin Diabetes Center, is a consultant for Abbott Nutrition.

Karen J. Kuc, MPH, Assistant Director, Grants and Projects, Joslin Diabetes Center, has no relevant financial relationships.

James E. Neighbours, Associate Director, Education Design, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.

Dr. Robert C. Stanton, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships.

Dr. Howard A. Wolpert, Director of the Insulin Pump Program and Senior Physician, Joslin Diabetes Center, is a consultant for Abbott Diabetes Care; Becton, Dickinson and Company; Insulet Corporation; and Novo Nordisk, Inc.

Accreditation and Designation of Credit

Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Joslin Diabetes Center designates this educational activity for a maximum of 1.50 AMA PRA Category 1 Credits.TM Physicians should only claim credit commensurate with the extent of their participation in the activity.

This CME activity was planned and produced in accordance with ACCME Essentials.

Participants not eligible for continuing medical education credit will receive a certificate of participation.

Estimated Time to Complete Activity: 1.5 hours

Computer Requirements

To participate in this activity, your computer will need the following hardware and software:

Credit Instructions

  1. Read the learning objectives, accreditation information, and faculty disclosures at the beginning of the activity.
  2. Read the text and view the slides.
  3. Complete the posttest and evaluation.
  4. Physicians who receive a grade of 70% or better on the posttest and who complete the evaluation will receive immediate CME credit.
  5. All other participants who receive a grade of 70% or better on the posttest and who complete the evaluation will receive a certificate of participation.

Questions About This Activity

For questions regarding the content of this activity, contact the accredited provider for this CME activity: cme@joslin.harvard.edu

Start Now

Page last updated: November 23, 2014